• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Sagent Pharmaceuticals, Inc. (SGNT)

    -NasdaqGS
    26.12 Up 1.95(8.07%) Dec 19, 3:59PM EST
    |After Hours : 26.12 Down 0.00 (0.02%) Dec 19, 5:35PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 65,359   69,194   70,869   64,106  
    Cost of Revenue46,589  46,602  50,485  46,847  
    Gross Profit 18,770   22,592   20,384   17,259  
    Operating Expenses
    Research Development3,677  10,037  4,020  4,646  
    Selling General and Administrative10,914  10,695  10,013  10,168  
    Non Recurring872   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 4,044   3,318   6,632   4,958  
    Income from Continuing Operations
    Total Other Income/Expenses Net(536)157  (86)(55)
    Earnings Before Interest And Taxes3,508  3,475  6,546  4,903  
    Interest Expense195  233  213  448  
    Income Before Tax3,313  3,242  6,333  4,455  
    Income Tax Expense1,387  173  1,214  895  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops2,663  4,527  5,400  6,073  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,926   3,069   5,119   3,560  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 1,926   3,069   5,119   3,560  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.